Anthony Atala to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Anthony Atala has written about Drug Resistance, Neoplasm.
Connection Strength
2.179
-
Atala A. Re: Acquisition of Tumorigenic Potential and Therapeutic Resistance in CD133+ Subpopulation of Prostate Cancer Cells Exhibiting Stem-Cell Like Characteristics. J Urol. 2019 01; 201(1):33.
Score: 0.647
-
Atala A. Re: Sphaeropsidin A Shows Promising Activity against Drug-Resistant Cancer Cells by Targeting Regulatory Volume Increase. J Urol. 2016 07; 196(1):280-1.
Score: 0.535
-
Atala A. Re: SAHA Triggered MET Activation Contributes to SAHA Tolerance in Solid Cancer Cells. J Urol. 2015 Sep; 194(3):848-9.
Score: 0.506
-
Atala A. Re: Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. J Urol. 2015 Apr; 193(4):1441-2.
Score: 0.491